FDG-PET imaging in the management of non-small-cell lung cancer

被引：9
|
作者：
Salminen, E
Mac Manus, M
机构：
[1] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland
[2] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia
来源：
ANNALS OF ONCOLOGY | 2002年 / 13卷 / 03期
关键词：
FDG-PET; non-small-cell lung cancer; outcome; staging; treatment;
D O I：
10.1093/annonc/mdf106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Lung cancer is currently the leading cause of cancer-related death in both men and women in most Western countries. Tumour stage is the strongest prognostic factor and the most important parameter guiding treatment decision making. Metabolic positron emission tomography imaging with fluorodeoxyglucose (FDG-PET) has consistently proved superior to conventional imaging for staging of non-small-cell lung cancer and provides information of greater prognostic significance than can be obtained using conventional approaches. FDG-PET has been approved in the USA. Germany and the UK as a basic and invaluable tool in the management of lung cancer.
引用
收藏
页码：357 / 360
页数：4
相关论文
共 50 条
  • [21] Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings
    Faria, Sergio L.
    Menard, Sonia
    Devic, Slobodan
    Sirois, Christian
    Souhami, Luis
    Lisbona, Robert
    Freeman, Carolyn R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04): : 1035 - 1038
  • [22] Analysis of tumor populations in non-small-cell lung cancer with FDG-PET according to pathological and genetic criteria
    El Yaagoubi, Y.
    Perraudeau, F.
    Barre, I.
    Guillet, J.
    Momboisse, D.
    Role, C.
    Bernard, O.
    Cauchois, A.
    Colin, J.
    Fagot, T.
    Nguyen, L.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2015, 39 (02): : 165 - 172
  • [23] Small cell lung cancer: role of FDG-PET and PET/CT
    Baum, R. R.
    Prasad, V.
    ONKOLOGE, 2008, 14 (08): : 774 - +
  • [24] IMAGING PET-CT imaging in non-small-cell lung cancer
    Levine, Mark
    Julian, Jim
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (11) : 619 - 620
  • [25] FDG-PET imaging for the staging and follow-up of small cell lung cancer
    Schumacher, T
    Brink, I
    Mix, M
    Reinhardt, R
    Herget, G
    Digel, W
    Henke, M
    Moser, E
    Nitzsche, E
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (04) : 483 - 488
  • [26] FDG-PET imaging in patients with paraneoplastic syndromes and suspected small cell lung cancer
    Crotty, E
    Patz, EF
    JOURNAL OF THORACIC IMAGING, 2001, 16 (02) : 89 - 93
  • [27] FDG-PET imaging for the staging and follow-up of small cell lung cancer
    Tilmann Schumacher
    Ingo Brink
    Michael Mix
    Michael Reinhardt
    Georg Herget
    Werner Digel
    Michael Henke
    Ernst Moser
    Egbert Nitzsche
    European Journal of Nuclear Medicine, 2001, 28 : 483 - 488
  • [28] FDG-PET/CT in non-small cell lung cancer with a small solid portion
    Krome, Susanne
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2021, 193 (04): : 375 - 375
  • [29] The prognostic relevance of response evaluation to chemotherapy by FDG-PET/CT in patients with metastatic non-small-cell lung cancer
    Selcuk, Nalan
    Toklu, Turkay
    Ordu, Cetin
    Uluc, Basak
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [30] FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence
    Croft, DR
    Trapp, J
    Kernstine, K
    Kirchner, P
    Mullan, B
    Galvin, J
    Peterson, MW
    Gross, T
    McLennan, G
    Kern, JA
    LUNG CANCER, 2002, 36 (03) : 297 - 301
12345